413 related articles for article (PubMed ID: 16890703)
1. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.
Sarma AV; McLaughlin JC; Wallner LP; Dunn RL; Cooney KA; Schottenfeld D; Montie JE; Wei JT
J Urol; 2006 Sep; 176(3):1108-13. PubMed ID: 16890703
[TBL] [Abstract][Full Text] [Related]
2. Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba.
Fernández L; Galán Y; Jiménez R; Gutiérrez A; Guerra M; Pereda C; Alonso C; Riboli E; Agudo A; González C
Int J Epidemiol; 2005 Feb; 34(1):193-7. PubMed ID: 15375086
[TBL] [Abstract][Full Text] [Related]
3. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
Sutcliffe S; Giovannucci E; De Marzo AM; Leitzmann MF; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2160-6. PubMed ID: 17119041
[TBL] [Abstract][Full Text] [Related]
4. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
[TBL] [Abstract][Full Text] [Related]
5. Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms.
Sutcliffe S; Giovannucci E; De Marzo AM; Willett WC; Platz EA
Am J Epidemiol; 2005 Nov; 162(9):898-906. PubMed ID: 16177142
[TBL] [Abstract][Full Text] [Related]
6. Prostatitis as a risk factor for prostate cancer.
Roberts RO; Bergstralh EJ; Bass SE; Lieber MM; Jacobsen SJ
Epidemiology; 2004 Jan; 15(1):93-9. PubMed ID: 14712152
[TBL] [Abstract][Full Text] [Related]
7. Self-report of prostatitis and its risk factors in a random sample of middle-aged men.
Rothman I; Stanford JL; Kuniyuki A; Berger RE
Urology; 2004 Nov; 64(5):876-9; discussion 879-80. PubMed ID: 15533468
[TBL] [Abstract][Full Text] [Related]
8. Medical history, sexual, and maturational factors and prostate cancer risk.
Lightfoot N; Conlon M; Kreiger N; Sass-Kortsak A; Purdham J; Darlington G
Ann Epidemiol; 2004 Oct; 14(9):655-62. PubMed ID: 15380796
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer and sexually transmitted diseases: a meta-analysis.
Taylor ML; Mainous AG; Wells BJ
Fam Med; 2005; 37(7):506-12. PubMed ID: 15988645
[TBL] [Abstract][Full Text] [Related]
10. Genital and urinary tract diseases and prostate cancer risk.
Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
[TBL] [Abstract][Full Text] [Related]
11. Is race a positive predictor of cancer on repeat prostate biopsy?
Yanke BV; Salzhauer EW; Colon I
J Urol; 2006 Sep; 176(3):1114-7. PubMed ID: 16890704
[TBL] [Abstract][Full Text] [Related]
12. Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration.
Sutcliffe S; Zenilman JM; Ghanem KG; Jadack RA; Sokoll LJ; Elliott DJ; Nelson WG; De Marzo AM; Cole SR; Isaacs WB; Platz EA
J Urol; 2006 May; 175(5):1937-42. PubMed ID: 16600802
[TBL] [Abstract][Full Text] [Related]
13. Relationship between body mass index and prostate cancer screening in the United States.
Scales CD; Curtis LH; Norris RD; Schulman KA; Dahm P; Moul JW
J Urol; 2007 Feb; 177(2):493-8. PubMed ID: 17222617
[TBL] [Abstract][Full Text] [Related]
14. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
[TBL] [Abstract][Full Text] [Related]
15. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
[TBL] [Abstract][Full Text] [Related]
16. Vasectomy and prostate cancer.
Lesko SM; Louik C; Vezina R; Rosenberg L; Shapiro S
J Urol; 1999 Jun; 161(6):1848-52; discussion 1852-3. PubMed ID: 10332451
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer risk assessment program: a 10-year update of cancer detection.
Giri VN; Beebe-Dimmer J; Buyyounouski M; Konski A; Feigenberg SJ; Uzzo RG; Hanks G; Godwin AK; Chen DY; Gordon R; Cescon T; Raysor S; Watkins-Bruner D
J Urol; 2007 Nov; 178(5):1920-4; discussion 1924. PubMed ID: 17868726
[TBL] [Abstract][Full Text] [Related]
18. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer.
Rosenblatt KA; Carter JJ; Iwasaki LM; Galloway DA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):763-8. PubMed ID: 12917208
[TBL] [Abstract][Full Text] [Related]
19. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
20. Prostate carcinogenesis and inflammation: emerging insights.
Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG
Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
